Decoding the genome of SARS-CoV-2: a pathway to drug development through translation inhibition
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes the coronavirus disease 2019 (COVID-19) pandemic and is continuously spreading globally. The continuous emergence of new SARS-CoV-2 variants keeps posing threats, highlighting the need for fast-acting, mutation-resistant broad-s...
Saved in:
| Main Authors: | Shan-Na Wu, Ting Xiao, Hui Chen, Xiao-Hong Li |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2024-12-01
|
| Series: | RNA Biology |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/15476286.2024.2433830 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Zinc pyrithione is a potent inhibitor of PLPro and cathepsin L enzymes with ex vivo inhibition of SARS-CoV-2 entry and replication
by: Jerneja Kladnik, et al.
Published: (2022-12-01) -
Identification of the Selenoprotein S Positive UGA Recoding (SPUR) element and its position-dependent activity
by: Eric M. Cockman, et al.
Published: (2024-12-01) -
N-alkyl and N-benzyl indoles are anti-SARS-CoV-2 agents and nsp13 inhibitors
by: Aurora Albano, et al.
Published: (2025-08-01) -
Sequential SAR-to-Optical Image Translation
by: Jingbo Wei, et al.
Published: (2025-07-01) -
Genomic surveillance of SARS-CoV-2 variants using pooled WGS
by: Inho Park, et al.
Published: (2025-04-01)